Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphocytic, Chronic, B-Cell

Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.

1,435 public trials 165 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphocytic, Chronic, B-Cell trial results

Completed

A Phase 2 Open-Label Study of the Efficacy and Safety of ABT-199 (GDC-0199) in Chronic Lymphocytic Leukemia (CLL) Subjects With Relapse or Refractory to B-Cell Receptor Signaling Pathway Inhibitor Therapy

NCT02141282

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Moores Cancer Center at UC San Diego /ID# 128535 La Jolla, California, United States
  • University of California, Los Angeles /ID# 127262 Los Angeles, California, United States
  • Stanford University School of Med /ID# 126495 Stanford, California, United States
  • Georgetown University Hospital /ID# 127261 Washington D.C., District of Columbia, United States
View all 15 locations
View Trial Details
Completed

iVAC-CLL01: Patient-individualized Peptide Vaccination After First Line Therapy of CLL

NCT02802943

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Katharinenhospital Stuttgart, Baden-Wurttemberg, Germany
  • Diakonie-Klinikum Stuttagrt Stuttgart, Baden-Wurttemberg, Germany
  • Marienhospital Stuttgart, Baden-Wurttemberg, Germany
  • Robert-Bosch-Krankenhaus Abteilung fuer Haematologie, Onkologie und Palliativmedizin Stuttgart, Baden-Wurttemberg, Germany
View Trial Details
Completed

Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

NCT01647971

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +33 more
Locations
  • TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States
  • TG Therapeutics Investigational Trial Site Jonesboro, Arkansas, United States
  • TG Therapeutics Investigational Trial Site Athens, Georgia, United States
  • TG Therapeutics Investigational Trial Site Macon, Georgia, United States
View Trial Details
Completed

Ublituximab + Ibrutinib in Select B-cell Malignancies

NCT02013128

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations
  • TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States
  • TG Therapeutics Investigational Trial Site Tucson, Arizona, United States
  • TG Therapeutics Investigational Trial Site Santa Barbara, California, United States
  • TG Therapeutics Investigational Trial Site Boulder, Colorado, United States
View all 18 locations
View Trial Details

Related conditions